Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12917462rdf:typepubmed:Citationlld:pubmed
pubmed-article:12917462lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:12917462lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:12917462lifeskim:mentionsumls-concept:C0019733lld:lifeskim
pubmed-article:12917462lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:12917462lifeskim:mentionsumls-concept:C0524637lld:lifeskim
pubmed-article:12917462lifeskim:mentionsumls-concept:C0003316lld:lifeskim
pubmed-article:12917462lifeskim:mentionsumls-concept:C0439064lld:lifeskim
pubmed-article:12917462lifeskim:mentionsumls-concept:C0439662lld:lifeskim
pubmed-article:12917462lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:12917462lifeskim:mentionsumls-concept:C2698650lld:lifeskim
pubmed-article:12917462lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:12917462pubmed:issuePt 9lld:pubmed
pubmed-article:12917462pubmed:dateCreated2003-8-14lld:pubmed
pubmed-article:12917462pubmed:abstractTextMHC-I-restricted cytotoxic responses are considered a critical component of protective immunity against viruses, including human immunodeficiency virus type 1 (HIV-1). CTLs directed against accessory and early regulatory HIV-1 proteins might be particularly effective; however, CTL epitopes in these proteins are rarely found. Novel artificial neural networks (ANNs) were used to quantitatively predict HLA-A2-binding CTL epitope peptides from publicly available full-length HIV-1 protein sequences. Epitopes were selected based on their novelty, predicted HLA-A2-binding affinity and conservation among HIV-1 strains. HLA-A2 binding was validated experimentally and binders were tested for their ability to induce CTL and IFN-gamma responses. About 69 % were immunogenic in HLA-A2 transgenic mice and 61 % were recognized by CD8(+) T-cells from 17 HLA-A2 HIV-1-positive patients. Thus, 31 novel conserved CTL epitopes were identified in eight HIV-1 proteins, including the first HLA-A2 minimal epitopes ever reported in the accessory and regulatory proteins Vif, Vpu and Rev. Interestingly, intermediate-binding peptides of low or no immunogenicity (i.e. subdominant epitopes) were found to be antigenic and more conserved. Such epitope peptides were anchor-optimized to improve immunogenicity and further increase the number of potential vaccine epitopes. About 67 % of anchor-optimized vaccine epitopes induced immune responses against the corresponding non-immunogenic naturally occurring epitopes. This study demonstrates the potency of ANNs for identifying putative virus CTL epitopes, and the new HIV-1 CTL epitopes identified should have significant implications for HIV-1 vaccine development. As a novel vaccine approach, it is proposed to increase the coverage of HIV variants by including multiple anchor-optimized variants of the more conserved subdominant epitopes.lld:pubmed
pubmed-article:12917462pubmed:languageenglld:pubmed
pubmed-article:12917462pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12917462pubmed:citationSubsetIMlld:pubmed
pubmed-article:12917462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12917462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12917462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12917462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12917462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12917462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12917462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12917462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12917462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12917462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12917462pubmed:statusMEDLINElld:pubmed
pubmed-article:12917462pubmed:monthSeplld:pubmed
pubmed-article:12917462pubmed:issn0022-1317lld:pubmed
pubmed-article:12917462pubmed:authorpubmed-author:BrunakSørenSlld:pubmed
pubmed-article:12917462pubmed:authorpubmed-author:MathiesenLars...lld:pubmed
pubmed-article:12917462pubmed:authorpubmed-author:ChaplinPaulPlld:pubmed
pubmed-article:12917462pubmed:authorpubmed-author:FomsgaardAnde...lld:pubmed
pubmed-article:12917462pubmed:authorpubmed-author:KronborgGitte...lld:pubmed
pubmed-article:12917462pubmed:authorpubmed-author:BuusSørenSlld:pubmed
pubmed-article:12917462pubmed:authorpubmed-author:VinnerLasseLlld:pubmed
pubmed-article:12917462pubmed:authorpubmed-author:CorbetSylvieSlld:pubmed
pubmed-article:12917462pubmed:authorpubmed-author:NielsenHenrik...lld:pubmed
pubmed-article:12917462pubmed:authorpubmed-author:LauemollerSan...lld:pubmed
pubmed-article:12917462pubmed:authorpubmed-author:TherrienDomin...lld:pubmed
pubmed-article:12917462pubmed:authorpubmed-author:TangSheilaSlld:pubmed
pubmed-article:12917462pubmed:issnTypePrintlld:pubmed
pubmed-article:12917462pubmed:volume84lld:pubmed
pubmed-article:12917462pubmed:ownerNLMlld:pubmed
pubmed-article:12917462pubmed:authorsCompleteYlld:pubmed
pubmed-article:12917462pubmed:pagination2409-21lld:pubmed
pubmed-article:12917462pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:meshHeadingpubmed-meshheading:12917462...lld:pubmed
pubmed-article:12917462pubmed:year2003lld:pubmed
pubmed-article:12917462pubmed:articleTitleOptimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes.lld:pubmed
pubmed-article:12917462pubmed:affiliationDepartment of Virology, Statens Serum Institut, 5 Artillerivej, DK-2300 Copenhagen S, Denmark.lld:pubmed
pubmed-article:12917462pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12917462pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12917462lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12917462lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12917462lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12917462lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12917462lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12917462lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12917462lld:pubmed